Rare Cancers: Charting a Faster Route to Treatment

Explore the challenges and promising developments in rare cancer treatment through this informative panel discussion. Delve into the unique obstacles faced by doctors, researchers, and patients dealing with rare cancers, including late-stage diagnoses, limited treatment options, and high drug costs. Discover how emerging technologies, improved diagnostics, targeted therapies, and pharmaceutical innovations are offering new hope. Learn about the potential of cancer immunology, innovative trial designs, and international data sharing in accelerating access to better treatments. Gain insights from experts as they discuss the Eliminate Cancer Initiative, immunotherapy advancements, clinical trial approaches, and the importance of international collaboration. Hear personal perspectives, including that of Baroness Tessa Jowell, and explore initiatives like the CRI Atlas. Understand the future directions of rare cancer research and treatment, including the potential of curative drugs and the significance of data sharing in advancing care for rare cancer patients.

Introduction
Welcome
Baroness Tessa Jowell
Eliminate Cancer Initiative
Perspective on Rare Cancer Research
Immunotherapy
What are we doing right
The future
Sharing data
Clinical trials
International collaboration
Count Me In
curative drugs
Jess Mills
Online Questions
CRI Atlas
Takeaways